1. Home
  2. TVRD vs REI Comparison

TVRD vs REI Comparison

Compare TVRD & REI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • REI
  • Stock Information
  • Founded
  • TVRD 2017
  • REI 2004
  • Country
  • TVRD United States
  • REI United States
  • Employees
  • TVRD N/A
  • REI N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • REI Oil & Gas Production
  • Sector
  • TVRD Health Care
  • REI Energy
  • Exchange
  • TVRD Nasdaq
  • REI Nasdaq
  • Market Cap
  • TVRD 246.5M
  • REI 241.9M
  • IPO Year
  • TVRD N/A
  • REI N/A
  • Fundamental
  • Price
  • TVRD $28.57
  • REI $0.75
  • Analyst Decision
  • TVRD Strong Buy
  • REI
  • Analyst Count
  • TVRD 2
  • REI 0
  • Target Price
  • TVRD $52.00
  • REI N/A
  • AVG Volume (30 Days)
  • TVRD 48.4K
  • REI 2.5M
  • Earning Date
  • TVRD 05-13-2025
  • REI 05-07-2025
  • Dividend Yield
  • TVRD N/A
  • REI N/A
  • EPS Growth
  • TVRD N/A
  • REI N/A
  • EPS
  • TVRD N/A
  • REI 0.36
  • Revenue
  • TVRD N/A
  • REI $335,642,768.00
  • Revenue This Year
  • TVRD N/A
  • REI $2.59
  • Revenue Next Year
  • TVRD N/A
  • REI $17.45
  • P/E Ratio
  • TVRD N/A
  • REI $2.06
  • Revenue Growth
  • TVRD N/A
  • REI N/A
  • 52 Week Low
  • TVRD $8.13
  • REI $0.72
  • 52 Week High
  • TVRD $34.31
  • REI $2.06
  • Technical
  • Relative Strength Index (RSI)
  • TVRD N/A
  • REI 37.13
  • Support Level
  • TVRD N/A
  • REI $0.72
  • Resistance Level
  • TVRD N/A
  • REI $0.94
  • Average True Range (ATR)
  • TVRD 0.00
  • REI 0.04
  • MACD
  • TVRD 0.00
  • REI -0.00
  • Stochastic Oscillator
  • TVRD 0.00
  • REI 14.57

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About REI Ring Energy Inc.

Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.

Share on Social Networks: